Chromocell Therapeutics Stock (AMEX: CHRO) stock price, news, charts, stock research, profile.
You can purchase shares of Chromocell Therapeutics (AMEX:CHRO) through any online brokerage.
Other companies in Chromocell Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI), Portage Biotech (NASDAQ:PRTG) and AquaBounty Techs (NASDAQ:AQB).
There is no analysis for Chromocell Therapeutics to provide a consensus price target.
The stock price for Chromocell Therapeutics (AMEX: CHRO) is $0.630001 last updated November 21, 2024 at 9:48 AM EST.
There are no upcoming dividends for Chromocell Therapeutics.
Chromocell Therapeutics’s Q4 earnings are confirmed for Thursday, February 20, 2025.
There is no upcoming split for Chromocell Therapeutics.
Chromocell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.